Staying up-to-date on the most effective and proven OA treatment guidelines and recommendations is crucial to helping your OA patients. These guidelines offer comprehensive and patient-centered treatment profiles to facilitate individualized treatment decisions regarding the management of OA.

When this module is completed, you will receive the “Module 2: OARSI 2019 Updated Treatment Guidelines” digital badge! However, to receive one CME credit, you must complete all five modules.

Learning Objectives:

By the end of this session, learners should be able to:

• Understand the foundational guidelines for treating OA as outlined by the OARSI 2019 treatment guidelines 
• Know the different levels of recommended treatments for OA of the knee
• Apply the treatment algorithm in clinical practice for OA of the knee 

Module Two Syllabus:

• The treatment algorithm and how to use it in clinical practice for patients with OA of the knee
• Core treatments for all patients with OA of the knee
• Level 1A, Level 1B, and Level 2 treatments for OA of the knee without comorbidities
• Level 1A, Level 1B, and Level 2 treatments for OA of the knee with gastrointestinal (GI) comorbidities
• Level 1A, Level 1B, and Level 2 treatments for OA of the knee with cardiovascular (CV) comorbidities
• Level 1A, Level 1B, and Level 2 treatments for OA of the knee with frailty
• Level 1A, Level 1B, and Level 2 treatments for OA of the knee with widespread pain and/or depression
• When to refer to orthopedic consultation
• Treatments recommended against
• Assessment questions

Meet the Instructors

• 
  Tim McAlindon

  Tim McAlindon is Natalie V. Zucker and Milton O. Zucker Chair in Rheumatology at Tufts University School of Medicine and Chief of Rheumatology, Allergy and Immunology at Tufts Medical Center. He is actively engaged in clinical research in the field of osteoarthritis, applying and developing methodologies in epidemiologic studies, clinical trials, systematic reviews, and treatment guidelines such as internet-based clinical trial methods (US patent 7259601); online case-control and case-crossover study designs; and mobile health applications. He directed the last two iterations of the OARSI Treatment Guidelines developed innovative patient-centered recommendations as well as a smartphone Application (Android and Apple). He has performed several large clinical trials testing novel interventions for osteoarthritis, including vitamin D, intra-articular corticosteroids, and Tai Chi. He is involved in developing an image-based evaluation of osteoarthritis structural progression that is under review as a biomarker by the FDA (MRI biomarkers of whole-knee OA severity and progression). His clinical research Lab provides a productive and dynamic environment for training and mentoring of pre-doctoral and postdoctoral fellows, and junior faculty members, in their research career development.

• 
  Søren T. Skou

  Søren T. Skou is a professor of exercise and human health at the University of Southern Denmark and head of the multiprofessional research unit PROgrez at Næstved, Slagelse, Ringsted Hospital. He has extensive research experience within the field of exercise as treatment of osteoarthritis and other chronic conditions. His overall professional aim is to advance clinical care of people with chronic conditions through evidence-based treatments developed, evaluated and implemented in a close, interprofessional collaboration between patients, clinicians and other stakeholders.